FDA: High-dose Diflucan might increase risk of birth defects

08/3/2011 | U.S. News & World Report

Pfizer's antifungal drug Diflucan, or fluconazole, appears to heighten the risk of certain birth defects when taken frequently in high dosage within the first trimester of pregnancy, according to an FDA warning. The agency reclassified from Category C to D the extended use of high-dose Diflucan for maternal indications other than vaginal yeast infection.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC